Sanofi

SAN · Euronext Paris · EUR

€70.81−3.13%−€2.29

Close · October 2, 2026

At a glance

Revenue growth: +5.49%; 2025 vs 2024
Net income growth: +40.52%; 2025 vs 2024
Net margin: 16.7%; 2024: 12.6%

Financial data

Amounts in millions of EUR; per-share values in EUR; shares in millions.

Balance sheet · Annual
Item	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Total assets	126,805	132,798	126,464	126,722	120,242	114,413	112,630	111,408	99,813	104,679
Current assets	30,952	42,588	30,670	34,111	30,653	33,786	28,936	24,647	26,388	33,112
Cash and equivalents	7,657	7,441	8,710	12,736	10,098	13,915	9,427	6,925	10,315	10,273
Short-term investments	810	486	270	663	—	—	—	—	—	—
Receivables	11,046	10,629	11,040	10,747	9,787	9,953	10,083	9,345	7,843	8,016
Inventory	10,214	9,431	9,666	8,960	8,715	8,352	7,994	7,477	6,818	6,896
Net property, plant and equipment	11,511	11,601	11,814	11,684	11,976	10,563	11,017	9,651	9,579	10,019
Goodwill	41,300	43,384	49,404	49,892	48,056	44,364	44,519	44,235	40,264	40,287
Other intangible assets	17,530	14,260	18,281	15,414	13,677	12,249	14,175	17,145	11,605	9,520
Long-term investments	6,854	3,259	2,666	2,765	2,422	2,105	5,266	5,531	5,379	2,892
Current liabilities	28,345	29,162	24,207	23,974	21,295	19,280	20,387	17,376	15,463	17,638
Accounts payable	7,361	7,551	7,328	6,813	6,180	5,295	5,313	5,041	4,633	4,297
Long-term debt	14,329	11,791	14,347	14,857	17,123	19,745	20,131	21,989	14,306	16,781
Total debt	20,170	17,713	18,220	21,048	22,226	23,390	25,628	24,371	15,364	18,378
Total liabilities	55,095	54,941	52,111	51,570	51,211	51,161	53,400	52,373	41,574	46,957
Total equity (incl. minority)	71,710	77,857	74,353	75,152	69,031	63,252	59,230	59,035	58,239	57,722
Minority interest	334	350	313	368	350	146	174	159	169	170